Vestal Point Capital, LP 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
VP Vestal Point Capital, LP | Institutional Filer | ▲ 31.20% | $3.58B | 90 |
Current Portfolio Holdings
Showing all 90 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines, Inc. | Healthcare | 2.4M | $231.0M | 6.46% |
| 2 | BMRN | BioMarin Pharmaceutical Inc. | Healthcare | 3.6M | $202.0M | 5.65% |
| 3 | ABVX | Abivax S.A. | Healthcare | 1.5M | $167.0M | 4.67% |
| 4 | NBIX | Neurocrine Biosciences, Inc. | Healthcare | 1.3M | $164.7M | 4.60% |
| 5 | ARWR | Arrowhead Pharmaceuticals, Inc. | Healthcare | 2.3M | $142.6M | 3.99% |
| 6 | ELVN | Enliven Therapeutics, Inc. | Healthcare | 3.3M | $127.4M | 3.56% |
| 7 | RGEN | Repligen Corporation | Healthcare | 925K | $109.0M | 3.05% |
| 8 | BCAX | Bicara Therapeutics Inc. Common Stock | Healthcare | 5.4M | $107.9M | 3.02% |
| 9 | NRIX | Nurix Therapeutics, Inc. | Healthcare | 6.5M | $100.8M | 2.82% |
| 10 | APGE | Apogee Therapeutics, Inc. | Healthcare | 1.1M | $92.6M | 2.59% |
| 11 | ASND | Ascendis Pharma A/S | Healthcare | 375K | $85.8M | 2.40% |
| 12 | IMCR | Immunocore Holdings plc | Healthcare | 2.8M | $83.4M | 2.33% |
| 13 | TSHA | Taysha Gene Therapies, Inc. | Healthcare | 18.0M | $80.5M | 2.25% |
| 14 | DYN | Dyne Therapeutics, Inc. | Healthcare | 4.0M | $72.5M | 2.03% |
| 15 | SNY | Sanofi | Healthcare | 1.4M | $67.5M | 1.89% |
Showing 1 to 15 of 90 holdings